TimeTeller GmbH

TimeTeller's innovative technology measures a patient's circadian rhythm through saliva samples to determine the optimal timing for cancer treatments using advanced computer algorithms. The mission is to reduce chemotherapy side effects and enhance treatment efficacy. Currently utilized in clinical studies at several hospitals, TimeTeller aims for widespread adoption to transform cancer therapy. Chronotherapy has the potential to improve tolerability and effectiveness by up to fivefold, but practical tools have been lacking—until now. TimeTeller bridges this gap, bringing this breakthrough from research to realworld application, with the goal of improving patients' quality of
life, increasing chemotherapy success rates, and reducing treatment costs.